Monotab (Isosorbide Mononitrate)

Isosorbide mononitrate releases nitric oxide in the bloodstream, which activates guanylate cyclase in smooth muscle cells. This raises cyclic GMP levels, causing the muscles to relax, dilating blood vessels, lowering cardiac preload and afterload, and enhancing oxygen delivery to the heart.

The specific dose of Monotab is determined by the prescribing healthcare professional based on the patient’s condition, response, and tolerance. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

The safety of isosorbide mononitrate in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Monotab, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Monotab (isosorbide mononitrate) is an organic nitrate that provides sustained nitric‑oxide release, whereas short‑acting nitrates like nitroglycerin act quickly but require more frequent dosing. Compared with beta‑blockers, Monotab primarily reduces cardiac workload through vasodilation rather than heart‑rate control.

Monotab tablets should be stored at temperatures below 25 °C, in their original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

Monotab is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s guidance on timing and any specific instructions related to meals.

Serious risks include severe hypotension, syncope, life‑threatening arrhythmias, and allergic reactions such as rash or swelling. Patients should seek immediate medical attention if they experience fainting, chest pain that does not improve, or signs of an allergic response.

Monotab should be avoided in patients with known hypersensitivity to isosorbide mononitrate or other organic nitrates, those who have taken phosphodiesterase‑5 inhibitors within 24 hours, and individuals with severe hypotension or certain cardiovascular conditions unless specifically directed by a physician.